Why the study?
Preclinical testing focuses primarily on lethal arrhythmias and cardiac electrophysiology, but many drugs also affect cardiac function beyond electrophysiology.
Key points are not available for this paper at this time.
Design
Review
Answers are grounded in this paper and cite their sources.
Broadens cardiotoxicity monitoring beyond electrophysiology; leaves open validation of shared pathways for targeted prevention.
Cardiotoxicity, defined as toxicity that affects the heart, is one of the most common adverse drug effects. Numerous drugs have been shown to have the potential to induce lethal arrhythmias by affecting cardiac electrophysiology, which is the focus of current preclinical testing. However, a substantial number of drugs can also affect cardiac function beyond electrophysiology. Within this broader sense of cardiotoxicity, this review discusses the key drug-protein interactions known to be involved in cardiotoxic drug response. We cover adverse effects of anticancer, central nervous system, genitourinary system, gastrointestinal, antihistaminic, anti-inflammatory, and anti-infective agents, illustrating that many share mechanisms of cardiotoxicity, including contractility, mitochondrial function, and cellular signaling.
No takes yet. Share an insight, caveat, or question.
Mamoshina et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: